This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haraldsson, K. Articles by Borg, A. Search for Related Content PubMed PubMed Citation Articles by Haraldsson, K. Articles by Borg, A.

BRCA2 Germ-Line Mutations Are Frequent in Male Breast Cancer Patients without a Family History of the Disease¹

Department of Oncology, University Hospital, S-221 85 Lund, Sweden

Breast cancer is a rare disease in men, affecting less than 0.1% of the male population. Two heritable gene defects have been associated with a predisposition to male breast cancer development, i.e., germ-line mutations in the breast cancer susceptibility gene BRCA2 and the androgen receptor (AR) gene. In this study, the entire coding regions of BRCA2 and AR were screened for mutations in 34 consecutive male breast cancer patients. Five different truncating BRCA2 mutations were identified in 7 (21%) of the 34 cases, with all mutations being of germ-line origin. Three of the mutated cases carried the same mutation (4186delG), which has been found earlier in two Swedish families with multiple female breast cancer cases. Haplotype analysis supported a common ancestry of 4186delG. One mutation, 6503delTT, was found in a male carrying also a previously identified COOH-terminal polymorphic stop codon (Lys3326ter). No differences were seen between mutation carriers and noncarriers with respect to clinical stage and estrogen or progesterone receptor status. Mutation carriers tended to be younger at diagnosis. No germ-line AR mutations were found in the present material, but the number of AR polyglutamine repeats tended to be lower among mutation carriers. Most surprisingly, only one of the seven BRCA2 mutation carriers had a positive family history of breast cancer, suggesting a lower penetrance of some BRCA2 mutations or an influence of modifying factors for disease development in males and females. The present study implies that approximately one-fifth of all male breast cancer cases in the Swedish population are due to germ-line BRCA2 mutations.

¹ Supported by grants from the Swedish Cancer Society, the Nordic Cancer Union, Mrs. Berta Kamprad's Foundation, the Gunnar Arvid and Elisabeth Nilsson Foundation, the John and Augusta Persson Foundation, the Hospital of Lund Foundations, and the King Gustav V Jubilee Foundation.

² To whom requests for reprints should be addressed, at Department of Oncology, University Hospital, S-221 85 Lund, Sweden. Fax: 46 46 147327; E-mail: ake.borg@onk.lu.se.

Received 11/25/97. Accepted 2/17/98.

This article has been cited by other articles:

				S. H. Giordano A Review of the Diagnosis and Management of Male Breast Cancer Oncologist, August 1, 2005; 10(7): 471 - 479. [Abstract] [Full Text] [PDF]

				J. R. Weiss, K. B. Moysich, and H. Swede Epidemiology of Male Breast Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 20 - 26. [Abstract] [Full Text] [PDF]

				A. Liede, B. Y. Karlan, and S. A. Narod Cancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature J. Clin. Oncol., February 15, 2004; 22(4): 735 - 742. [Abstract] [Full Text] [PDF]

				R. J. Brenner, J. N. Weitzel, N. Hansen, and P. Boasberg Screening-detected Breast Cancer in a Man with BRCA2 Mutation: Case Report Radiology, February 1, 2004; 230(2): 553 - 555. [Abstract] [Full Text] [PDF]

				E. Kwiatkowska, M. Teresiak, V. Filas, A. Karczewska, D. Breborowicz, and A. Mackiewicz BRCA2 Mutations and Androgen Receptor Expression as Independent Predictors of Outcome of Male Breast Cancer Patients Clin. Cancer Res., October 1, 2003; 9(12): 4452 - 4459. [Abstract] [Full Text] [PDF]

				L. Ottini, G. Masala, C. D'Amico, B. Mancini, C. Saieva, G. Aceto, D. Gestri, V. Vezzosi, M. Falchetti, M. De Marco, et al. BRCA1 and BRCA2 Mutation Status and Tumor Characteristics in Male Breast Cancer: A Population-based Study in Italy Cancer Res., January 15, 2003; 63(2): 342 - 347. [Abstract] [Full Text] [PDF]

				S. H. Giordano, A. U. Buzdar, and G. N. Hortobagyi Breast Cancer in Men Ann Intern Med, October 15, 2002; 137(8): 678 - 687. [Abstract] [Full Text] [PDF]

				A. Auvinen, R. E. Curtis, and E. Ron Risk of Subsequent Cancer Following Breast Cancer in Men J Natl Cancer Inst, September 4, 2002; 94(17): 1330 - 1332. [Abstract] [Full Text] [PDF]

				E Kwiatkowska, I Brozek, E Izycka-Swieszewska, J Limon, and A Mackiewicz Novel BRCA2 mutation in a Polish family with hamartoma and two male breast cancers J. Med. Genet., July 1, 2002; 39(7): e35 - 35. [Full Text] [PDF]

				N. Loman, O. Johannsson, U. Kristoffersson, H. Olsson, and A. Borg Family History of Breast and Ovarian Cancers and BRCA1 and BRCA2 Mutations in a Population-Based Series of Early-Onset Breast Cancer J Natl Cancer Inst, August 15, 2001; 93(16): 1215 - 1223. [Abstract] [Full Text] [PDF]

				M. J. Jayo, T. C. Register, C. L. Hughes, U. Blas-Machado, E. Sulistiawati, H. Borgerink, and C. S. Johnson Effects of an Oral Contraceptive Combination With or Without Androgen on Mammary Tissues: A Study in Rats Reproductive Sciences, July 1, 2000; 7(4): 257 - 265. [Abstract] [PDF]

				C. S. Sinclair, R. Berry, D. Schaid, S. N. Thibodeau, and F. J. Couch BRCA1 and BRCA2 Have a Limited Role in Familial Prostate Cancer Cancer Res., March 1, 2000; 60(5): 1371 - 1375. [Abstract] [Full Text]

				I E YOUNG, K M KURIAN, M A F MACKENZIE, I H KUNKLER, B B COHEN, M L HOOPER, A H WYLLIE, and C M STEEL The CAG repeat within the androgen receptor gene in male breast cancer patients J. Med. Genet., February 1, 2000; 37(2): 139 - 140. [Full Text]

				B. H. Spain, C. J. Larson, L. S. Shihabuddin, F. H. Gage, and I. M. Verma Truncated BRCA2 is cytoplasmic: Implications for cancer-linked mutations PNAS, November 23, 1999; 96(24): 13920 - 13925. [Abstract] [Full Text] [PDF]

				B. Csokay, N. Udvarhelyi, Z. Sulyok, I. Besznyak, S. Ramus, B. Ponder, and E. Olah High Frequency of Germ-Line BRCA2 Mutations among Hungarian Male Breast Cancer Patients without Family History Cancer Res., March 1, 1999; 59(5): 995 - 998. [Abstract] [Full Text] [PDF]